Senthil Vel Sundaram - Net Worth and Insider Trading
Senthil Vel Sundaram Net Worth
The estimated net worth of Senthil Vel Sundaram is at least $3 Million dollars as of 2024-05-01. Senthil Vel Sundaram is the CFO of Nightstar Therapeutics PLC and owns about 126,886 shares of Nightstar Therapeutics PLC (NITE) stock worth over $3 Million. Senthil Vel Sundaram is also the CEO of Terns Pharmaceuticals Inc and owns about 9,770 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $49,339. Details can be seen in Senthil Vel Sundaram's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Senthil Vel Sundaram has not made any transactions after 2023-05-31 and currently still holds the listed stock(s).
Transaction Summary of Senthil Vel Sundaram
Senthil Vel Sundaram Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Senthil Vel Sundaram owns 5 companies in total, including Sio Gene Therapies Inc (SIOX) , Nightstar Therapeutics PLC (NITE) , and Terns Pharmaceuticals Inc (TERN) among others .
Click here to see the complete history of Senthil Vel Sundaram’s form 4 insider trades.
Insider Ownership Summary of Senthil Vel Sundaram
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SIOX | Sio Gene Therapies Inc | 2019-06-27 | director |
| NITE | Nightstar Therapeutics PLC | 2019-06-07 | Chief Financial Officer |
| TERN | Terns Pharmaceuticals Inc | 2023-05-31 | director & Chief Executive Officer |
| DNAA | Social Capital Suvretta Holdings Corp I | 2021-09-24 | director |
| AKLI | Akili Inc | 2021-09-24 | director |
Senthil Vel Sundaram Latest Holdings Summary
Senthil Vel Sundaram currently owns a total of 2 stocks. Among these stocks, Senthil Vel Sundaram owns 126,886 shares of Nightstar Therapeutics PLC (NITE) as of April 1, 2019, with a value of $3 Million and a weighting of 98.49%. Senthil Vel Sundaram also owns 9,770 shares of Terns Pharmaceuticals Inc (TERN) as of May 31, 2023, with a value of $49,339 and a weighting of 1.51%.
Latest Holdings of Senthil Vel Sundaram
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NITE | Nightstar Therapeutics PLC | 2019-04-01 | 126,886 | 25.41 | 3,224,173 |
| TERN | Terns Pharmaceuticals Inc | 2023-05-31 | 9,770 | 5.05 | 49,339 |
Holding Weightings of Senthil Vel Sundaram
Senthil Vel Sundaram Form 4 Trading Tracker
According to the SEC Form 4 filings, Senthil Vel Sundaram has made a total of 0 transactions in Nightstar Therapeutics PLC (NITE) over the past 5 years. The most-recent trade in Nightstar Therapeutics PLC is the sale of 391 shares on April 1, 2019, which brought Senthil Vel Sundaram around $9,896.
According to the SEC Form 4 filings, Senthil Vel Sundaram has made a total of 3 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Terns Pharmaceuticals Inc is the acquisition of 2,111 shares on May 31, 2023, which cost Senthil Vel Sundaram around $2,977.
Insider Trading History of Senthil Vel Sundaram
- 1
Senthil Vel Sundaram Trading Performance
GuruFocus tracks the stock performance after each of Senthil Vel Sundaram's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Senthil Vel Sundaram is 34.6%. GuruFocus also compares Senthil Vel Sundaram's trading performance to market benchmark return within the same time period. The performance of stocks bought by Senthil Vel Sundaram within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Senthil Vel Sundaram's insider trading performs compared to the benchmark.
Performance of Senthil Vel Sundaram
Average Return
235.28%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.99 | 34.6 | 96 | 235.28 | ||
| Relative Return to S&P 500(%) | 25.28 | 34.22 | 92.12 | 228.73 |
Senthil Vel Sundaram Ownership Network
Ownership Network List of Senthil Vel Sundaram
Ownership Network Relation of Senthil Vel Sundaram
Senthil Vel Sundaram Owned Company Details
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
Senthil Vel Sundaram is the director of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
Senthil Vel Sundaram Mailing Address
Above is the net worth, insider trading, and ownership report for Senthil Vel Sundaram. You might contact Senthil Vel Sundaram via mailing address: Nightstar Therapeutics Plc, 203 Crescent Street, Suite 303, Waltham Ma 02453.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
